Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

AtaiBeckley Inc.

ATAI · — · CIK 0002081043 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

19 Form 4 transaction lines observed in the same window
3 sales · 16 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Craig Kevin JamesChief Medical Officer
○▼○
Kochendoerfer GerdChief Operating Officer
○▼
HERSHBERG ROBERTDirector
○▼
Rao SrinivasSee remarks
○
Johnson Anne NagengastChief Accounting Officer
○
Barrett Christopher Ryan CaveSee remarks
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 4 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
6Sales
23Other Form 4 lines
15SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING3 sale line(s) · context only
OTHER16 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+1.7%
3M
—
6M
—
12M
—

Volatility & liquidity

Volatility
8.8%
Beta
—
Avg daily value
—

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
—
ROE
-297.5%
Industry
Pharmaceutical Preparations

Market data

Price data up to: 2026-10-08 · Price source: OpenBB/yfinance · From SEC filings: ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

29 transaction lines in the latest 365-day window; 29 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Smiley Andrea HeslinD (D)Common Stock4,666USD —USD —SEC filing ↗
2026-09-11Short Glenn FrankD (D)Common Stock42,333USD —USD —SEC filing ↗
2026-09-11Rao SrinivasD (D)Common Stock216,442USD —USD —SEC filing ↗
Show recent Form 4 evidence (20 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Smiley Andrea HeslinD (D)Common Stock4,666USD —USD —SEC filing ↗
2026-09-11Short Glenn FrankD (D)Common Stock42,333USD —USD —SEC filing ↗
2026-09-11Rao SrinivasD (D)Common Stock216,442USD —USD —SEC filing ↗
2026-09-11Kalali Amir HD (D)Common Stock4,666USD —USD —SEC filing ↗
2026-09-11Johnson Anne NagengastD (D)Common Stock140,045USD —USD —SEC filing ↗
2026-09-11Craig Kevin JamesD (D)Common Stock8,437USD —USD —SEC filing ↗
2026-09-11Barrett Christopher Ryan CaveD (D)Common Stock155,066USD —USD —SEC filing ↗
2026-09-11Angermayer Christian; Apeiron Investment Group Ltd.D (D)Common Stock55,756,748USD —USD —SEC filing ↗
2026-07-07HERSHBERG ROBERTSale (S)Common Stock100,000USD 4.96USD 496,000SEC filing ↗
2026-07-07HERSHBERG ROBERTOption exercise / conversion (M)Common Stock100,000USD 1.35USD 135,000SEC filing ↗
2026-06-26Kochendoerfer GerdSale (S)Common Stock50,000USD 5.00USD 250,000SEC filing ↗
2026-06-26Kochendoerfer GerdOption exercise / conversion (M)Common Stock50,000USD 1.60USD 80,000SEC filing ↗
2026-06-25Craig Kevin JamesSale (S)Common Stock42,579USD 4.51USD 192,031SEC filing ↗
2026-06-25Craig Kevin JamesOption exercise / conversion (M)Common Stock42,579USD 1.43USD 60,820SEC filing ↗
2026-04-20Craig Kevin JamesSale (S)Common Stock42,579USD 5.00USD 212,895SEC filing ↗
2026-04-20Craig Kevin JamesOption exercise / conversion (M)Common Stock42,579USD 1.62USD 69,070SEC filing ↗
2026-04-08Angermayer Christian; Apeiron Investment Group Ltd.Option exercise / conversion (M)Common Stock559,232USD 1.60USD 897,297SEC filing ↗
2026-03-20Craig Kevin JamesSale (S)Common Stock100,000USD 3.55USD 355,000SEC filing ↗
2026-03-20Craig Kevin JamesOption exercise / conversion (M)Common Stock100,000USD 1.26USD 125,608SEC filing ↗
2026-01-02Feilding-Mellen CosmoSale (S)Common Stock39,594USD 3.90USD 154,417SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerATAI
CIK0002081043
SectorHealthcare
Industry— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
Exchange—

Data coverage

Local Form 4 history29 transaction lines from 2026-01-02 to 2026-09-11
0 P purchase lines · 6 S sale lines · 23 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.